Blepharitis is an inflammatory condition of the eyelid margins and likely to be the most underdiagnosed, undertreated, and underappreciated eye disease worldwide. 1 Traditionally, clinicians classify it into anterior or posterior blepharitis, with the latter associated with meibomian gland dysfunction and the former with local microbial colonisation or seborrhoea.
In the past, the terminology of blepharitis has been vague but over the past few years, the International Workshop on Meibomian Gland Dysfunction have produced a series of publications aimed to clarify the classification and summarise the literature on aetiology, pathophysiology, and treatment. [1] [2] [3] However, blepharitis remains a diagnostic enigma, with a variety of treatments with variable levels of efficacy, reflecting the poor understanding of aetiology.
In this issue, Dadaci et al 4 investigated the microbial flora of the eyelid margin and show excessive microbial colonisation of the lids in patients with blepharitis. The authors found that fungal elements were detected with periodic acid-Schiff staining in approximately four out of five patients with chronic anterior blepharitis. 4 Fungi, specifically Pityrosporum yeasts, have been implicated in blepharitis as early as in 1990; in a placebo-controlled clinical trial, published in Eye, treatment with ketoconazole 2% cream on the lid margins markedly improved the clinical severity of blepharitis. 5 Coagulase-negative Staphylococcus, Staphylococcus aureus, and Propionibacterium acnes are common commensal microbes that may contribute to the pathophysiology of blepharitis. 6 Dadaci et al, 4 also found that there were high levels of Demodex infestation. Other investigations of Demodex show that infestation of lash follicles is associated with the occurrence of anterior blepharitis. 7 In a large study involving 335 patients, the number of Demodex mites correlated significantly with the severity of ocular surface discomfort; treatment with tea tree oil reduced the Demodex counts and improved subjective ocular symptoms. 8 The variety of pathogens implicated in blepharitis may also explain the beneficial effect of broadspectrum treatments, such as lid scrubs with tea tree oil and shampoo. Tea tree oil exerts not only anti-Demodex properties, but also broader antibacterial, antifungal, and anti-inflammatory actions that may enhance its therapeutic potential. 1, 9 However, the presence of microbes on the lid margin of patients with blepharitis does not imply causality. Excessive colonisation may be an epiphenomenon, indicating the possibility that microbes find the altered eyelid environment in blepharitis more hospitable than that of the normal eyelid. Keratinisation of the lid margin epithelium, keratinised cell debris, and the abnormal lipids in blepharitis all provide a rich substrate for microbial pathogens. 1 Patients with chronic blepharitis are often treated with antibiotics and steroid drops, a treatment that may also alter the resident commensal flora and favour excessive colonisation with selective bacterial or fungal microbes.
It must be emphasised though that this alteration of conjunctival microbial flora does not represent an infection. In addition, the matter is made more complex in the presence of posterior blepharitis where the primary aetiology is the occurrence of meibomian gland dysfunction.
Irrespective of whether fungi, bacteria or other pathogens are the primary cause of blepharitis, there is strong suspicion that excessive microbial colonisation contributes to the pathophysiology of the condition. Bacterial lipases and toxins could alter the lipid composition and destabilise the tear film, with the production of toxic-free fatty acids, causing evaporative dry eye. 10 The secondary production of pro-inflammatory cytokines, neutrophil chemotaxis, and reactive oxygen species production are all pathogenic to the ocular surface. 1 The detrimental role that microbes may have in blepharitis is also supported by the beneficial effect antibiotics have in patients with this condition.
Progress in elucidating the aetiology of this poorly understood condition, as demonstrated by the work of Dadaci et al 4 and others is being made. With greater research in this area and greater acceptance of the diagnostic criteria set up by international workshops, more target specific and long-term treatments for patients with blepharitis will no doubt emerge. In the meantime, clinicians are left with making pragmatic options to reduce microbial flora based on their own experience. Anyone for a drop of tea tree oil shampoo?
